未登录Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group
Weiss, L.; Fischer, L. E.; Heinemann, V.; Gieseler, F.; Hoehler, T.; Mayerle, J.; Quietzsch, D.; Reinacher-Schick, A.; Schenk, M.; Seipelt, G.; Siveke, J. T.; Stahl, M.; Kaiser, U.; Waldschmidt, D. T.; Dorman, K.; Zhang, D.; Westphalen, C. B.; Boeck, S.; Haas, M. .png)
分享.png)
收藏Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialPouyiourou, Maria; Kraft, Bianca N.; Wohlfromm, Timothy; Stahl, Michael; Kubuschok, Boris; Loeffler, Harald; Hacker, Ulrich T.; Huebner, Gerdt; Weiss, Lena; Bitzer, Michael; Ernst, Thomas; Schuett, Philipp; Hielscher, Thomas; Delorme, Stefan; Kirchner, Martina; Kazdal, Daniel; Ball, Markus; Kluck, Klaus; Stenzinger, Albrecht; Bochtler, Tilmann; Kraemer, Alwin 分享 收藏 Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trialPouyiourou, M.; Kraft, B.; Wohlfromm, T.; Stahl, M.; Kubuschok, B.; Loeffler, H.; Hacker, U. T.; Huebner, G.; Westphalen, C. B.; Bitzer, M.; Ernst, T.; Schuett, P.; Hielscher, T.; Delorme, S.; Stenzinger, A.; Bochtler, T.; Kraemer, A. 分享 收藏 Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' methodHaas, M.; Waldschmidt, D. T.; Stahl, M.; Reinacher-Schick, A.; Freiberg-Richter, J.; von Weikersthal, L. Fischer; Kaiser, F.; Kanzler, S.; Frickhofen, N.; Seufferlein, T.; Dechow, T.; Mahlberg, R.; Malfertheiner, P.; Illerhaus, G.; Kubicka, S.; Abdul-Ahad, A.; Snijder, R.; Kruger, S.; Westphalen, C. B.; Held, S.; Von Bergwelt-Baildon, M.; Boeck, S.; Heinemann, V 分享 收藏 Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta in Healthy Subjects: A Randomized, Double-blind Trial拟议的Pegfilgrastim生物仿制药MSB11455与参考Pegfilgrastim Neulasta在健康受试者中的药代动力学和药效学: 一项随机，双盲试验Lickliter, Jason; Kanceva, Radmila; Vincent, Emmanuelle; Schueler, Armin; Harrison-Moench, Eleanor; Yue, Corinne Seng; Stahl, Michael; Ullmann, Martin; Ghori, Vishal; Griffin, Paul 分享 收藏 Decrease in plasma membrane tension triggers PtdIns(4,5)P2 phase separation to inactivate TORC2Riggi, Margot; Niewola-Staszkowska, Karolina; Chiaruttini, Nicolas; Colom, Adai; Kusmider, Beata; Mercier, Vincent; Soleimanpour, Saeideh; Stahl, Michael; Matile, Stefan; Roux, Aurelien; Loewith, Robbie 分享 收藏 分享 收藏 Target of Rapamycin Complex 2 Regulates Actin Polarization and Endocytosis via Multiple PathwaysRispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Vaga, Stefania; Bodenmiller, Bernd; Abraham, Yann; Filipuzzi, Ireos; Movva, N. Rao; Aebersold, Ruedi; Helliwell, Stephen B.; Loewith, Robbie 分享 收藏 TORC2 Signaling Pathway Guarantees Genome Stability in the Face of DNA Strand BreaksShimada, Kenji; Filipuzzi, Ireos; Stahl, Michael; Helliwell, Stephen B.; Studer, Christian; Hoepfner, Dominic; Seeber, Andrew; Loewith, Robbie; Movva, N. Rao; Gasser, Susan M. 分享 收藏 Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3LHuber, Alexandre; French, Sarah L.; Tekotte, Hille; Yerlikaya, Seda; Stahl, Michael; Perepelkina, Mariya P.; Tyers, Mike; Rougemont, Jacques; Beyer, Ann L.; Loewith, Robbie 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB:: long-term results of a phase II trialEberhardt, W; Stamatis, G; Stuschke, M; Wilke, H; Müller, MR; Kolks, S; Flasshove, M; Schütte, J; Stahl, M; Schlenger, L; Budach, V; Greschuchna, D; Stüben, G; Teschler, H; Sack, H; Seeber, S 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
